Literature DB >> 6601931

Scarring as a factor affecting the eradication of microorganisms from the kidney in pyelonephritis.

T Miller.   

Abstract

The inability of antimicrobial agents to penetrate scarred renal tissue may explain some therapeutic failures. We examined the effect of scarring on antimicrobial therapy by using a unique animal model in which both kidneys were infected to the same degree but only one kidney was scarred. Scar formation could not explain the failure of ampicillin or nitrofurantoin to eradicate renal infection, but co-trimoxazole was less effective in the presence of tissue damage and scar formation than in their absence.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6601931      PMCID: PMC184680          DOI: 10.1128/AAC.23.3.500

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  4 in total

1.  Furadantin.

Authors:  G CARROLL; R V BRENNAN
Journal:  J Urol       Date:  1954-05       Impact factor: 7.450

2.  Intrarenal distribution of ampicillin in the normal and diseased human kidney.

Authors:  A Whelton; D G Sapir; G G Carter; M A Garth; W G Walker
Journal:  J Infect Dis       Date:  1972-05       Impact factor: 5.226

3.  Acquiescent renal infection.

Authors:  T E Miller; D North; S Burnham
Journal:  Kidney Int       Date:  1975-06       Impact factor: 10.612

4.  Pyelonephritis: the relationship between infection, renal scarring, and antimicrobial therapy.

Authors:  T Miller; S Phillips
Journal:  Kidney Int       Date:  1981-05       Impact factor: 10.612

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.